Effect of Treatment With Insulin Sensitizer on Arterial Properties, Metabolic Parameters and Liver Function in Patients With Nonalcoholic Fatty Liver Disease

NCT01084486 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

OTHER_GOV

Sponsor class

Conditions

Nonalcoholic Fatty Liver Disease

Interventions

DRUG: Metformin

Sponsor

Wolfson Medical Center